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Summary
Adhesive contact between pre- and postsynaptic neurons initiates synapse formation during brain
development and provides a natural means of trans-synaptic signaling. Numerous adhesion
molecules and their role during synapse development have been described in detail. However,
once established, the mechanisms of adhesive disassembly and its function in regulating synaptic
transmission have been unclear. Here, we report that synaptic activity induces acute proteolytic
cleavage of neuroligin-1 (NLG1), a postsynaptic adhesion molecule at glutamatergic synapses.
NLG1 cleavage is triggered by NMDA receptor activation, requires Ca2+/calmodulin-dependent
protein kinase, and is mediated by proteolytic activity of matrix metalloprotease 9 (MMP9).
Cleavage of NLG1 occurs at single activated spines, is regulated by neural activity in vivo, and
causes rapid destabilization of its presynaptic partner neurexin-1β (NRX1β). In turn, NLG1
cleavage depresses synaptic transmission by abruptly reducing presynaptic release probability.
Thus, local proteolytic control of synaptic adhesion tunes synaptic transmission during brain
development and plasticity.
Introduction
Neuronal synapses are maintained by a complex network of adhesion molecules that span
the synaptic cleft and juxtapose the presynaptic active zone with the postsynaptic density
(Dalva et al., 2007). The tight association between pre- and postsynaptic elements has long
suggested that changes on either side of the synapse are transmitted trans-synaptically
(Lisman and Harris, 1993). Indeed, postsynaptic receptor blockade augments presynaptic
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function through unknown mechanisms (Burrone et al., 2002; Murthy et al., 2001;
Thiagarajan et al., 2005; Wierenga et al., 2006), whereas increased activity in dendritic
segments retrogradely dampens release probability of contacting presynaptic terminals
(Branco et al., 2008). Given their confined localization at synapses and restricted number of
interactions, postsynaptic adhesion molecules offer the potential for tight local control over
presynaptic function (Futai et al., 2007; Gottmann, 2008; Ko et al., 2009; Missler et al.,
2003; Restituito et al., 2011; Stan et al., 2010). However, whether trans-synaptic adhesion
acutely regulates synapse function is unclear.
Neuroligins (NLGs) are postsynaptic adhesion molecules that bind presynaptic neurexins
(NRXs) with nanomolar affinity (Sudhof, 2008). Rodents have four NLG isoforms, each
exhibiting a specific expression pattern and subcellular distribution. In particular, NLG1 and
NLG2 are localized to excitatory and inhibitory synapses, respectively (Graf et al., 2004).
NLGs and NRXs contain intracellular domains that interact with scaffold proteins such as
PSD-95 and CASK (Sudhof, 2008). Adhesion between NLGs and NRXs thus provides a
structural bridge between pre- and postsynaptic scaffolding machinery. In humans, NRXs
and NLGs have been strongly linked to autism spectrum disorders, emphasizing the
importance of this trans-synaptic complex for normal brain development (Sudhof, 2008).
Indeed, NLGs induce functional maturation of presynaptic terminals (Dean et al., 2003;
Scheiffele et al., 2000; Wittenmayer et al., 2009), whereas NRXs cluster postsynaptic
proteins (Graf et al., 2004; Heine et al., 2008).
Their ability to trans-aggregate synaptic components implicated NLGs and NRXs as critical
mediators of synapse formation. This hypothesis was supported by in vitro studies showing
that NLG levels correlate with the number of synapses generated during development (Chih
et al., 2005; Dean et al., 2003; Graf et al., 2004; Levinson et al., 2005). However, NLG1-3
triple knockout (KO) neurons exhibit normal synapse number and ultrastructural synaptic
features but present severe deficits in synaptic transmission (Varoqueaux et al., 2006),
indicating that in vivo, NLGs are not required for the initial stages of synaptogenesis but are
critical for proper synaptic function. Recent studies have further shown that NLGs regulate
NMDA (Chubykin et al., 2007; Jung et al., 2010) and AMPA (Etherton et al., 2011; Heine et
al., 2008; Shipman et al., 2011) receptor function and are involved in multiple forms of
synaptic plasticity across species (Choi et al., 2011; Jung et al., 2010).
Interestingly, overexpression of NLG1 in hippocampal slices and cultured neurons increases
release probability through NRX-dependent mechanisms (Futai et al., 2007; Ko et al., 2009;
Stan et al., 2010) whereas disruption of endogenous NLG-NRX interactions with soluble Fc-
NRX fragments decreases mEPSC frequency and release probability (Levinson et al., 2005).
In vivo, transgenic expression of NLG1 results in extended active zones and increased
number of reserve pool vesicles (Dahlhaus et al., 2010) while neurons lacking αNRX1-3
exhibit deficits in synaptic transmission due to impaired N-type Ca2+ channel function
(Missler et al., 2003). These results suggest that the NLG-NRX trans-synaptic complex is an
important regulator of presynaptic function. However, a limitation of most studies to date is
the reliance on long-term manipulations susceptible to indirect compensatory mechanisms.
High frequency stimulation of cultured hippocampal neurons induces fast morphological
changes of NLG1 puncta (Gutierrez et al., 2009), indicating that NLG1 can be acutely
regulated by activity. Yet, the underlying mechanisms, activity-dependent signals, and
functional consequences of acute NLG1 regulation at synapses remain unknown.
Matrix metalloproteases (MMPs) are a large family of secreted Zn2+-dependent proteolytic
enzymes that cleave extracellular matrix components and pericellular proteins. MMP2,
MMP3, and MMP9 are highly abundant in the brain and have been associated with
synaptogenesis, synaptic plasticity, and multiple neuropathological conditions (Ethell and
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Ethell, 2007; Yong, 2005). In particular, MMP9 is acutely upregulated and secreted in
response to neuronal activity and is required for the expression of LTP (Bozdagi et al., 2007;
Nagy et al., 2006; Wang et al., 2008). Moreover, MMP9 activity is increased following
epileptic seizures in the hippocampus and is required for post-seizure synaptic plasticity and
circuit remodeling (Szklarczyk et al., 2002; Wilczynski et al., 2008). Despite a well-
documented role in regulating synapse function and plasticity (Bozdagi et al., 2007;
Michaluk et al., 2009; Nagy et al., 2006), the substrates of MMP9 associated with functional
remodeling of glutamatergic synapses remain unclear.
In the present study, we demonstrate that synaptic activity triggers rapid MMP9-mediated
proteolysis of synaptic NLG1. Cleavage of NLG1 is ubiquitous in the brain, occurs
throughout development, and is upregulated by neuronal activity in mature and developing
circuits. Using a combination of biochemical, live cell imaging, and electrophysiological
analysis, we show that postsynaptic cleavage of NLG1 occurs at single activated dendritic
spines, requires NMDA receptor and Ca2+-calmodulin-dependent kinase (CaMK) signaling,
and causes rapid destabilization of presynaptic NRX1β. Acute NLG1 cleavage in turn
suppresses synaptic strength by rapidly reducing presynaptic release probability. Together,
our results indicate that postsynaptic activity influences presynaptic function by NLG1
cleavage, revealing a post-translational mechanism of NLG1 regulation that contributes to
synapse plasticity in vivo. Activity-dependent cleavage of synaptic adhesion complexes may
provide a general paradigm for trans-synaptic signaling in diverse neural circuits.
Results
Neuronal Activity Induces Rapid Loss of Synaptic NLG1
To determine the effect of neuronal activity on synaptic NLGs, we treated dissociated
DIV21 cortical cultures with 30 mM KCl for 2 h. Endogenous NLG levels were assessed by
immunocytochemistry using a pan-NLG antibody directed against the C-terminal domain of
NLG1-4. PSD-95 immunolabeling was used to identify glutamatergic synapses. Following
KCl treatment, pan-NLG levels at PSD95+ dendritic spines was reduced by 29.5 ± 5.3%
relative to control (Figures 1A and 1B). A similar change was observed in total pan-NLG
levels (28.9 ± 1.1% decrease after KCl) indicating a net loss of NLGs across the entire cell
(Figure 1B). NLG1 predominantly partitions to and regulates glutamatergic synapses
(Chubykin et al., 2007; Graf et al., 2004). The loss of NLGs from PSD95+ sites prompted us
to test whether depolarization depletes NLG1 from the postsynaptic density (PSD). Due to
the lack of NLG1-specific antibodies suitable for immunocytochemistry, we performed
biochemical fractionation of DIV21 cortical cultures after KCl stimulation (Ehlers, 2003)
and measured NLG1 levels using an antibody targeted against the extracellular N-terminal
domain. Immunoblot analysis of isolated fractions revealed enrichment of NLG1 in the PSD
(Figure S1). KCl depolarization resulted in a significant loss (47.6 ± 1.8%) of NLG1 from
total extracts (Figures 1C and 1D). This reduction in NLG1 was observed in both synaptic
plasma membrane (SPM) and PSD fractions (30.5 ± 1.5% decrease in SPM; 23.9 ± 7.3% in
PSDI; 45.1 ± 5.4% in PSDIII) and was particularly pronounced in Triton-insoluble PSDII
fractions (72.9 ± 4.9% reduction), in which NLG1 is most highly enriched (Figure S1).
We next tested whether KCl incubation increases NLG1 internalization and lysosomal
degradation using surface biotinylation (Ehlers, 2000). To inhibit lysosomal proteolysis,
cells were pre-incubated with leupeptin for 1 h. In basal conditions, 5.3 ± 1.2% of surface
NLG1 was internalized over 2 h (Figures 1E and 1F). This low internalization rate was
unaltered by KCl (5.7 ± 0.8% of surface NLG1 internalized), indicating that KCl-induced
NLG1 loss is not due to increased internalization. By contrast, GluA1 receptor exhibited a
marked increase in internalization upon KCl stimulation (Figure 1F, right panel), similar to
previous reports (Ehlers, 2000). We further addressed whether KCl-induced loss of total
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NLG1 was sensitive to proteasome or lysosome inhibition. Incubation with KCl for 2 h
resulted in a 48.1 ± 2.6% reduction of total NLG1 levels which was unaffected by
proteasome inhibition (MG132, 50 μM), blockade of lysosomal degradation (leupeptin, 200
μM), or both together (MG132, 51.5 ± 5.7%; leupeptin, 46.3 ± 6.7%; both, 47.4 ± 4.2% of
control; Figures 1G and 1H). However, incubation with the broad-spectrum matrix
metalloprotease (MMP) inhibitor GM6001 (10 μM) abolished KCl-induced loss of NLG1
(102.9 ± 1.1% of control; Figures 1G and 1H), whereas incubation with GM6001, MG132,
or leupeptin alone did not alter NLG1 levels under basal conditions (MG132, 103.6 ± 4.4%;
leupeptin, 102.1 ± 0.8%; GM6001, 109.8 ± 5.1% of control; Figures S1B and S1C).
Juxtamembrane Cleavage of Neuroligin-1 Releases its N-Terminal Ectodomain
To test whether NLG1 is cleaved at the plasma membrane, we developed a novel assay
based on surface biotinylation (Figure 2A). Briefly, DIV21 neuronal cultures were
covalently labeled with cell impermeable biotin (Sulfo-LC-Biotin-NHS, 1 mg/ml) to
exclusively label surface proteins. Following incubation at 37°C, culture media was
collected, centrifuged, and incubated overnight with streptavidin beads to isolate released
soluble biotin conjugates prior to immunoblot analysis. Using this assay we detected
accumulation of ~90 kDa soluble polypeptide(s) recognized by N-terminal NLG1 antibody
(NLG1-N) in the media (Figure 2B). To control for possible artifacts generated by
biotinylation, we filtered media from unbiotinylated neuronal cultures using a 30 kDa cutoff
filter and similar ~90 kDa bands were detected in the concentrated fractions (Figure S2A).
Initially postulated as breakdown products (Ichtchenko et al., 1995), ~90 kDa NLG1 species
have been widely observed and considered to be immature unglycosylated forms of NLG1
(Ko et al., 2009; Scheiffele et al., 2000). To test whether ~90 kDa NLG1 polypeptide(s)
correspond to immature or incompletely glycosylated isoforms, we enzymatically
deglycosylated N- and O-linked glycans from media-collected biotinylated fractions and
examined electrophoretic mobility. Deglycosylation resulted in equivalent migration shift of
full length and soluble ~90 kDa NLG1 species (Figure 2C), identifying the latter as cleaved
NLG1 N-terminal fragments (NLG1-NTFs) rather than immature non-glycosylated species.
To determine if NLG1 is cleaved in vivo, we analyzed soluble fractions of cortical,
hippocampal, and cerebellar tissue from adult P60 mice (Figure 2D). Several NLG1 bands
of ~90 kDa were present in all brain fractions, indicating that multiple cleavage fragments
are generated in vivo. Enzymatic deglycosylation of these fractions also resulted in a
migration shift of NLG1-NTFs, indicating that they originate from mature forms of NLG1
(Figures 2E and S2B). To exclude possible antibody non-specificity, we tested whether
similar bands were detected in extracts of NLG1 knockout (KO) mice (Varoqueaux et al.,
2006). Both 110 kDa full form and ~90 kDa NLG1-NTFs were absent in NLG1 KO brain
extracts and respective soluble fractions (Figure 2F), confirming that the NTFs detected
correspond to cleaved NLG1. To characterize the developmental profile of NLG1 cleavage,
we performed immunoblot analysis of mouse cortical fractions from birth to adulthood (P1–
P60, Figure 2G). Interestingly, NLG1-NTFs are present throughout development and are
enriched during the first postnatal week (P1–P7) where they are as abundant as full-length
NLG1 (Figures 2G and 2H).
A logical outcome of N-terminal proteolysis is the generation of corresponding intracellular
C-terminal fragments (CTFs). Analysis of mouse cortical fractions using an antibody
targeted against the C-terminal domain of NLG1 revealed multiple membrane-associated
~20 kDa species, a size consistent with the predicted mass of a NLG1-CTFs based on the
size of NLG1-NTFs (Figure 2I). These bands are absent in NLG1-KO brain extracts
confirming that they correspond to NLG1 fragments (Figure 2J). To confirm these findings,
we expressed a dually tagged version of NLG1 with N-terminal GFP and C-terminal HA
(GFP-NLG1-HA) in COS7 cells. Immunoblot analysis of cell extracts using an anti-HA
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antibody revealed the presence of ~20 kDa bands in lysates from cells expressing GFP-
NLG1-HA but not GFP-NLG1 (Figure S2C).
Neuronal Activity Induces Cleavage of Neuroligin-1 Through an NMDAR-CaMK-MMP9
Signaling Pathway
Combining our biotinylation-based assay with pharmacological manipulation of DIV21
cortical neuron cultures we assessed how neuronal activity regulates NLG1 cleavage.
Whereas preventing action potentials with tetrodotoxin (TTX, 2 μM) decreased NLG1-NTFs
(0.65 ± 0.06 of control), increasing network activity with bicuculline (50 μM) and 4-
aminopyridine (4AP, 25 μM) significantly increased NLG1 cleavage (Bic/4AP, NLG-NTF
levels: 1.5 ± 0.1 of control; Figures 3A and 3B). To mimic conditions that induce robust loss
of synaptic NLG1 (Figure 1), we depolarized neurons with 30mM KCl for 2 h.
Depolarization led to a pronounced increase in NLG1-NTFs (4.4 ± 0.5 fold) compared to
control conditions (Figures 3C and 3D). This effect was abrogated by the NMDA receptor
antagonist APV (50 μM, 1.0 ± 0.2 of control) whereas APV alone induced no change in
NLG1-NTF levels in basal conditions (APV, 0.95 ± 0.1 of control, Figure S3A and S3B).
Moreover, brief 5 min incubation with 50 μM NMDA induced a robust increase in NLG1-
NTFs indicating that NMDA receptor activation is both necessary and sufficient to trigger
NLG1 cleavage. By contrast, the selective AMPA receptor antagonist NBQX (20 μM) failed
to abrogate KCl-induced cleavage (NMDA, 2.4 ± 0.1; KCl+NBQX, 1.92 ± 0.1; NBQX, 1.37
± 0.1; Figures S3A and S3B). In addition, CaMK inhibitors KN93 (5 μM) and KN62 (10
μM), but not the inactive isomer KN92 (5 μM), also abrogated KCl-induced increase in
NLG1-NTFs (KN93, 1.5 ± 0.3; KN62, 1.5 ± 0.4; KN92, 5.0 ± 0.8 fold increase in NLG1-
NTFs relative to control; Figures 3C and 3D) indicating that activity dependent NLG1
cleavage is further regulated by CaMK signaling.
What enzyme is responsible for NLG1 cleavage? Using biotinylation-based isolation of
NLG-NTFs, we found that the broad spectrum MMP inhibitor GM6001 (10 μM) prevented
activity-induced cleavage of NLG1 (fold increase relative to control: KCl, 2.5 ± 0.2; KCl +
GM6001, 0.8 ± 0.2; Figures 3E and 3F). MMP2, MMP3 and MMP9 are the most abundant
MMPs in the brain and have been implicated in several forms of synaptic plasticity (Ethell
and Ethell, 2007; Yong, 2005). Incubation with MMP2/9 inhibitor II (0.3 μM) or MMP9/13
inhibitor I (20 nM) blocked KCl-induced NLG1 cleavage (NLG1-NTFs relative to control:
KCl + MMP2/9i, 0.6 ± 0.1; KCl + MMP9/13i, 0.4 ± 0.1; Figures 3E and 3F). Importantly,
the selective MMP2 inhibitor III (50 μM), or MMP13 inhibitor I (0.5 μM) had no significant
effect on NLG1 cleavage (NLG1-NTFs relative to control: KCl + MMP2i, 2.5 ± 0.1; KCl +
MMP13i 2.7 ± 0.4; Figures 3E and 3F). Interestingly, GM6001, MMP2/9 inhibitor I, and
MMP9/13 inhibitor I, but not MMP2 inhibitor III, MMP3 inhibitor III, or MMP13 inhibitor
I, also reduced NLG1 cleavage under basal conditions (NLG1-NTFs relative to control:
GM6001, 0.46 ± 0.09; MMP2i, 0.85 ± 0.13; MMP3i, 0.94 ± 0.13; MMP2/9i, 0.47 ± 0.11;
MMP9/13i, 0.27 ± 0.11; MMP13i, 0.92 ± 0.15; Figures S3C and S3D) indicating that
MMP9 dependent cleavage is active not only during periods of elevated neuronal activity
but also under basal conditions. Moreover, we noted that MMP3 inhibitor III (50 μM)
induced a partial but non-significant decrease in NLG1-NTFs after KCl (KCl + MMP3i, 1.7
± 0.1, p = 0.092, Figures 3E and 3F). MMPs are secreted as inactive zymogens and require
cleavage of their prodomains to become enzymatically active (Ethell and Ethell, 2007).
Thus, the effect of MMP3 inhibition could be due to impaired MMP9 activation. To
determine which MMP is the terminal protease cleaving NLG1, we treated neurons with 4-
aminophenylmercuric acetate (APMA), a compound that non-selectively activates all MMPs
by cleaving their prodomains (Van Wart and Birkedal-Hansen, 1990), and tested the effect
of specific MMP inhibitors. Brief incubation of DIV21 cortical neurons with 0.5 mM
APMA for 15 min induced robust generation of NLG1-NTFs (3.8 ± 0.8 fold increase
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relative to control; Figures 3G and 3H). Co-incubation with MMP2/9 inhibitor II (0.3 μM)
blocked APMA-induced cleavage (0.6 ± 0.1) whereas MMP2 inhibitor III (50 μM) and
MMP3 inhibitor III (50 μM) had no effect (3.8 ± 1.0 and 3.2 ± 0.8 respectively), indicating
that MMP9 is the downstream protease responsible for cleavage of NLG1. To further
validate these findings, we tested how NLG1 is regulated by activity in neurons lacking
MMP9. KCl depolarization of DIV17-18 WT mouse cortical cultures for 2 h resulted in
extensive loss of NLG1 (0.36 ± 0.01 relative to control; Figure 3I). By contrast, KCl
incubation of MMP9 KO cultures induced no loss of NLG1 (0.90 ± 0.04 relative to control;
Figure 3J), confirming that MMP9 is responsible for activity-dependent regulation of NLG1.
To characterize the activity-dependent production of NLG1-CTFs, we measured CTF levels
in whole cell extracts of DIV21 dissociated neuron cultures treated with KCl. As expected,
KCl incubation increased NLG1-CTF levels (1.6 ± 0.4 compared to control; Figures S3E
and S3F). Interestingly, inhibition of the γ-secretase complex with DAPT (20 μM) during
KCl treatment resulted in increased accumulation of NLG1-CTFs (KCl+DAPT, 3.7 ± 0.8;
Figures S3E and S3F), indicating that NLG1 is processed by the γ-secretase complex
following ectodomain cleavage.
Extracellular Cleavage of NLG1 Occurs Near Its Transmembrane Domain
Deglycosylation of NLG1-NTFs produces ~70 kDa species (Figure 2E) which, based on
amino acid mass, indicates that proteolysis occurs in the extracellular juxtamembrane region
of NLG1. To determine the specific domain targeted for cleavage, we generated a series of
mutants with sequential deletions and amino acid (aa) replacements in the juxtamembrane
domain (Figure 4A). NLG1 mutants were screened for their resistance to APMA cleavage
using biotinylation-based labeling and isolation of NLG1-NTFs in COS7 cells. Brief
incubation with APMA resulted in robust shedding of GFP-NLG1 (Figure 4B). This effect
was blocked by GM6001, confirming that MMPs cleave NLG1 under these conditions
(Figure 4B). Substituting 60 aa of the NLG1 stalk domain (aa 636–695) with the polylinker
GAAAAA resulted in a mutant (NLG1-ΔSDfull) that is resistant to APMA (Figures 4A and
4B). Within this 60 residue stretch, deletion of aa 672–695 (NLG1-ΔSD3) and replacement
with the polylinker GAAAAA likewise abolished APMA-induced cleavage whereas
mutation of more membrane-distal sequences did not (aa 636–660, NLG1-ΔSD1; aa 654–
677, NLG1-ΔSD2). Notably, we attempted to further resolve the precise cleavage site, but
shorter deletions or single site mutants were all cleaved upon APMA treatment, potentially
due to the presence of multiple MMP target sequences within this domain. Importantly, the
ΔSD3 mutation does not alter NLG1 localization, as GFP-NLG1-ΔSD3 exhibited a similar
distribution pattern and synaptic enrichment as wild-type GFP-NLG1 when expressed in
DIV21 hippocampal neurons (Figure S4A). Moreover, GFP-NLG1-ΔSD3 and GFP-NLG1
induced quantitatively similar spine formation when expressed in mouse cortical neurons in
vivo from E15.5 to P17-18, indicating that GFP-NLG1-ΔSD3 retains the synaptogenic
properties of wild-type NLG1 (Figures S4D and S4E). To address if NLG1-ΔSD3 is
resistant to activity-dependent cleavage in neurons, we tested the effect of KCl
depolarization on GFP-NLG1 and GFP-NLG1-ΔSD3. Following 2 h of KCl incubation,
synaptic GFP-NLG1 fluorescence decreased to 55.9 ± 5.4% of initial value whereas GFP-
NLG1-ΔSD3 exhibited no change upon KCl treatment (101.9 ± 6.9% of initial fluorescence
level; Figures S4A and S4B).
Rapid Cleavage of NLG1 in Dendritic Spines Following Local Glutamate Uncaging
To address if NLG1 cleavage occurs locally in response to increased synaptic activity, we
released glutamate at single dendritic spines by two-photon laser-induced photolysis of (4-
methoxy-7-nitroindolinyl)-glutamate (MNI-glutamate) while imaging dendrites of neurons
expressing GFP-NLG1-WT or GFP-NLG1-ΔSD3 (Figures 4C–4L). Analysis was performed
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in CA1 pyramidal neurons in organotypic hippocampal slices at a time corresponding to P14
with tdTomato (tdT) co-expression used as a cell fill. Stimulation near (~1 μm) the distal
head of a dendritic spine (Spine 1) with 80 4-ms laser pulses at 2 Hz induced rapid loss of
spine GFP-NLG1 within 1 min, whereas no change in fluorescence was detected in the
neighboring dendritic shaft (ΔGFP/tdT: Spine 1: 0.61 ± 0.04, Dendrite: 1.01 ± 0.02; Figures
4C, 4F and 4J). We observed a smaller, partial loss of NLG1-GFP in neighboring spines
(Spine 2, ΔGFP/tdT: 0.79 ± 0.15) possibly due to the diffusion of intracellular signals.
Incubation with the MMP2/9 inhibitor II (0.3 μM) or GM6001 (10μM) abrogated glutamate
induced GFP-NLG1 loss (MMP2/9i: ΔGFP/tdT: Spine 1, 0.89 ± 0.10; Spine 2, 0.97 ± 0.12;
Dendrite, 0.98 ± 0.11; Figures 4D, 4G and 4K; GM6001: ΔGFP/tdT: Spine 1, 0.91 ± 0.04;
Dendrite, 0.96 ± 0.03; Figures S4F–S4H). Moreover, the cleavage resistant GFP-NLG1-
ΔSD3 was also unaffected by glutamate uncaging (ΔGFP/tdT: Spine 1, 0.99 ± 0.05; Spine 2,
0.96 ± 0.11; Dendrite, 1.05 ± 0.04; Figures 4E, 4H and 4L).
Cleavage of NLG1 Destabilizes Presynaptic Neurexin-1β
To address how NLG1 cleavage affects synaptic function, we developed a system to acutely
and selectively cleave NLG1 on demand (Figure 5A and Movie S1). For this, we inserted
the Thrombin (Thr) proteolytic recognition sequence LVPRGS into the stalk domain of
NLG1 downstream of the dimerization domain, replacing the endogenous sequence
TTTKVP. In these experiments, the NLG1ΔA splice variant lacking splice site A was
chosen due to its stringent partitioning into excitatory synapses (Chih et al., 2006). This Thr-
cleavable mutant (GFP-Thr-NLG1) localized to synapses in a manner indistinguishable from
wild-type GFP-NLG1 in DIV21 hippocampal neurons (Figures 5A–5D). Incubation with 5
U/ml Thr for 30 min resulted in rapid and extensive reduction of GFP-Thr-NLG1 synaptic
fluorescence (fractional fluorescence remaining; 0.20 ± 0.03; Figures 5A–5G; Movie S1).
Control neurons transfected with GFP-NLG1 lacking a Thr recognition sequence exhibited
no change in GFP fluorescence upon Thr treatment (fractional fluorescence remaining; 0.99
± 0.02; Figure 5H and Movie S2 right panel), indicating that the reduced GFP fluorescence
was not due to photobleaching. To determine how acute NLG1 shedding affects
postsynaptic morphology and integrity, we co-transfected neurons with mCherry (mCh) or
PSD-95-mCh and compared fluorescence changes after 30 min of Thr incubation. No
significant changes in spine volume measured by the mCh cell fill (mCh fluorescence ratio
post/pre thrombin; 1.04 ± 0.03; Figures 5A, 5F, and Movie S1) or PSD-95-mCh puncta
intensity (PSD-95-mCh fluorescence ratio post/pre thrombin; 0.97 ± 0.02; Figures 5B and
5F) were detected after Thr treatment.
To test whether acute cleavage of NLG1 regulates presynaptic NRX1β, we sequentially
transfected neuronal cultures with GFP-Thr-NLG1 and NRX1β–mCh lacking splice site 4,
obtaining distinct populations of neurons expressing each construct. This approach
generated pre- and postsynaptic pairs labeled with NRX1β-mCh and GFP-Thr-NLG1,
respectively. At dually-labeled synapses, acute Thr treatment caused a rapid and pronounced
decrease in NRX1β-mCh fluorescence (Figures 5E–5G and Movie S2; fractional
fluorescence remaining; 0.51 ± 0.04). Further analysis of the kinetics of GFP-Thr-NLG1 and
NRX1β-mCh level at higher sampling rate revealed that loss of both proteins occurs in
tandem (Figures S5A–S5D). Importantly, there was no detectable change in presynaptic
synaptophysin-mCh signal intensity (fractional fluorescence remaining; 0.99 ± 0.08) under
similar conditions (Figures 5D and 5F), indicating that destabilization of NRX1β by NLG1
cleavage is specific and not due to indirect structural changes in presynaptic terminals. This
was further confirmed by immunolabeling of the vesicular glutamate transporter VGLUT1,
which was unaffected by acute NLG1 cleavage (Figure S5E–S5G).
Peixoto et al. Page 7













NLG1 Cleavage Decreases Synaptic Strength by Reducing Presynaptic Release
To define the physiological effects induced by acute NLG1 cleavage, we used whole-cell
electrophysiological recordings to measure synaptic transmission on DIV15-25 hippocampal
neurons expressing GFP-Thr-NLG1 for 3–5 d. This system allowed us to monitor synaptic
transmission in the same neuron before and after selective Thr-induced cleavage of NLG1.
Recordings from neurons expressing GFP-NLG1 lacking a Thr cleavage site were used to
control for possible off-target effects of Thr activity. We first examined the effect of NLG1
cleavage on miniature excitatory postsynaptic currents (mEPSCs, Figure 6A). Application of
Thr reduced mEPSC frequency (44 ± 10% of baseline; Figures 6B and S6A) with no
significant effect on amplitude (91 ± 8% of baseline; Figures 6C and S6A) indicating that
NLG1 ectodomain cleavage does not change postsynaptic AMPA receptor number or
function, but rather reduces neurotransmitter release or decreases the number of functional
excitatory synapses. By contrast, Thr had no effect on mEPSCs in neurons expressing GFP-
NLG1 (mEPSC frequency, 100 ± 3% of baseline; amplitude, 102 ± 4% of baseline; Figures
6A–6C and S6B). Importantly, there was no difference in baseline mEPSCs between
neurons expressing GFP-NLG1 (frequency, 1.74 ± 0.44 s−1; amplitude, 11.66 ± 1.70 pA)
and GFP-Thr-NLG1 (frequency, 2.00 ± 0.36 s−1; amplitude 10.74 ± 0.61 pA). Consistent
with the predominant localization of NLG1 to glutamatergic synapses (Chubykin et al.,
2007; Graf et al., 2004), NLG1 cleavage failed to alter miniature inhibitory postsynaptic
current (mIPSC) frequency or amplitude (mIPSC frequency, 103 ± 3%; mIPSC amplitude,
98 ± 8% of baseline; Figures S6C–S6F), indicating that NLG1 cleavage does not acutely
alter GABAergic transmission.
The reduction in mEPSC frequency (Figures 6A, 6B, and S6A) together with the
destabilization of NRX1β (Figures 5C–5G) suggested a possible alteration in presynaptic
function. To test this further, we examined the effects of Thr-induced NLG1 cleavage on
evoked excitatory synaptic currents (eEPSCs) and their paired-pulse responses. Evoked
responses were elicited by stimulating nearby cells with an inter-stimulus interval of 100 ms.
Neurons expressing GFP-NLG1 or GFP-Thr-NLG1 exhibited similar baseline paired-pulse
ratio (PPR) responses (GFP-NLG1, 1.42 ± 0.12; GFP-Thr-NLG1, 1.59 ± 0.46). Recordings
were then made on the same cell before and after thrombin application. Thrombin treatment
of neurons expressing GFP-Thr-NLG1 reduced the amplitude of the first response and
increased PPR (eEPSC amplitude, 50 ± 18% of baseline; PPR, 139 ± 8% of baseline;
Figures 6D–6F), strongly suggesting that NLG1 cleavage decreases the probability of
neurotransmitter release. This effect was not attributable to Thr treatment per se, as there
was no change in eEPSC amplitude or PPR in neurons expressing GFP-NLG1 lacking a Thr
cleavage sequence (eEPSC amplitude, 95 ± 8% of baseline; PPR, 106 ± 6% of baseline;
Figures 6D–6F).
To address whether specific blockade of NLG1 cleavage also alters release probability, we
expressed GFP-NLG1 or GFP-NLG1-ΔSD3 in DIV17 hippocampal neurons and compared
FM4-64 unloading kinetics from contacting presynaptic terminals at DIV21 (Figures 6G–
6I). To increase basal rate of NLG1 cleavage, cultures were incubated with bicuculline (50
μM) and 4AP (25 μM) 2 d prior to imaging (Figures 3A and 3B). Interestingly, terminals
apposing synapses with GFP-NLG1-ΔSD3 exhibited faster FM4-64 unloading kinetics (τ =
46.1 ± 1.2 s; Figure 6G) than terminals contacting GFP-NLG1-expressing cells (τ= 60.5 ±
1.5 s), indicating that blocking NLG1 cleavage increases presynaptic release probability.
NLG1 is Cleaved by MMP-9 in Response to Increased Neuronal Activity in Mature and
Developing Circuits
To address whether cleavage of NLG1 is regulated by activity in vivo, we measured NLG1-
NTFs generated during pilocarpine-induced status epilepticus (PSE) in mice. Intraperitoneal
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administration of pilocarpine in P60 mice induced robust seizures and resulted in a 2.2 ± 0.3
fold increase of soluble NLG1-NTFs in the hippocampus after 2 h PSE (Figures 7A–7C). To
test whether MMP9 is involved in PSE-induced NLG1 cleavage, we performed pilocarpine
injections in MMP9 KO mice. Notably, 2 h PSE characterized by robust behavioral seizures
failed to elevate soluble NLG1-NTFs in MMP9 KO hippocampus (1.1 ± 0.1 relatively to
control, Figures 7B and 7C). As a control for epileptic activity, both WT and MMP9 KO
mice exhibited upregulation of the activity-regulated protein Arc/Arg3.1 after PSE (Figure
7B).
Given the enrichment of NLG1-NTFs during the first postnatal weeks (Figures 2G and 2H),
we addressed whether NLG1 cleavage is regulated by sensory experience during
development. For this, we subjected mice to 5 d of dark rearing (DR) from P21–P26, a
period of heightened sensory-evoked refinement of visual cortical circuits (Hensch, 2004),
and subsequently re-exposed them to light for a brief period of 2 h (DR+2hL, Figure 7D).
This protocol induces rapid synaptic remodeling in visual cortex and results in extensive
molecular, functional, and structural synaptic changes (Philpot et al., 2001; Tropea et al.,
2010). With this paradigm, 2 h of re-exposure to light after 5 d of DR caused an increase in
NLG1 cleavage in the visual cortex of WT mice (DR, 1.0 ± 0.1; DR+2hL, 1.5 ± 0.2,
relatively to LR group; Figures 7E and 7F) but not in MMP9 KO animals (DR, 0.9 ± 0.1;
DR+2hL, 1.0 ± 0.1; relative to LR group). Together these findings indicate that increased
neuronal activity in vivo triggers MMP9-dependent cleavage of NLG1 in both mature and
developing circuits.
Discussion
Cleavage and Loss of Neuroligin-1 from Synapses
Although implicated in diverse forms of activity-dependent synaptic maturation and
plasticity (Choi et al., 2011; Chubykin et al., 2007; Jung et al., 2010), it has been unclear
whether neuroligins acutely regulate synapse function and whether the neuroligin-neurexin
trans-synaptic complex undergoes dynamic dissociation. Here we have shown that increased
neuronal activity decreases synaptic NLG1 in minutes. MMP inhibitors, but not lysosome or
proteasome inhibitors, block this effect, indicating that under these conditions NLG1 is
predominantly regulated by MMP proteolytic cleavage (Figures 1G and 1H). The extent of
endogenous NLG1 loss from synapses observed using biochemical methods is greater than
that observed by immunostaining (Figure 1). This disparity may be attributed to the broad
specificity of the pan-NLG antibody used for immunolabeling and to the fact that it targets
the C-terminal domain of NLGs, an epitope that is further regulated by the γ-secretase
complex (Figures S3E and S3F). It will be important to address how other NLG isoforms are
regulated by MMPs, and whether NLG1-CTFs participate in intracellular signaling.
Multiple soluble NLG1-NTF species can be detected in brain (Figure 2D), suggesting that
NLG1 contains more than one cleavage site. This observation provides a plausible
explanation for why single amino acid point mutations in the juxtamembrane region of
NLG1 fail to prevent MMP-dependent cleavage, which instead requires substitution of a 24
amino acid segment (Figures 4A and 4B). Moreover, basal levels of NLG1-NTFs can be
detected in brain extracts from MMP9 KO mice (Figure 7B), indicating the existence of
MMP9-independent mechanisms cleaving NLG1. In addition, our data indicate that NLG1-
NTFs are most abundant during the first postnatal weeks (Figures 2G and 2H) suggesting
that NLG1 cleavage may have different functions during development. It will be important
to define in detail the activity-independent and MMP9-independent mechanisms of NLG-1
cleavage and their specific role in synapse development and plasticity. Nevertheless, our
results indicate that MMP9 is required for activity-dependent cleavage of NLG1 in multiple
cellular contexts in vivo (Figure 7) and in vitro (Figures 3 and 4), consistent with the known
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involvement of MMP9 in multiple forms of synaptic plasticity (Bozdagi et al., 2007; Nagy
et al., 2006; Szklarczyk et al., 2002; Wang et al., 2008; Wilczynski et al., 2008).
Focal uncaging of glutamate triggers MMP9-dependent cleavage of postsynaptic NLG1,
indicating that this mechanism is regulated locally (Figures 4C and 4J). Interestingly, we
detected a small heterosynaptic decrease of GFP-NLG1 from neighboring dendritic spines
after synaptic stimulation (Figures 4C and 4J) suggesting that MMP9 activation may spread
to adjacent dendritic regions. It remains unclear how NMDAR/CaMK signaling couples to
MMP9 activity, however considering the presence of MMP9 in spino-dendritic
tubulovesicular structures (Wilczynski et al., 2008), one possibility is that CaMK activation
triggers exocytosis of MMP9 containing vesicles in nearby dendritic regions or spines
(Kennedy and Ehlers, 2011). It will be interesting to address if persistent cleavage of NLG1
can induce dendrite-wide effects, and how the surface pools of NLGs are redistributed and
replenished following periods of increased MMP-9 activity.
Neuroligin Cleavage as a Trans-Synaptic Retrograde Signal
Acute ectodomain cleavage of postsynaptic NLG1 causes rapid loss of NRX1β from
apposing presynaptic terminals (Figures 5C, 5E, and 5G). The presynaptic protein
synaptophysin is not affected by NLG1 cleavage indicating that shedding of NLG1 is not
accompanied by gross structural changes in presynaptic terminals (Figures 5D and 5F).
Considering the expanding set of trans-synaptic NRX binding partners these results suggest
that postsynaptic NLG1 is an important regulator of NRX1β stability at synapses. Previous
studies have shown that deletion of αNRXs in mice reduces action-potential-evoked
neurotransmitter release due to impaired presynaptic Ca2+ channel function (Missler et al.,
2003). However, due to the role of NRXs in synapse maturation, it has been unclear whether
this effect is due to indirect developmental effects or reflects an ongoing role of NRXs in
neurotransmitter release. Using the highly selective thrombin-induced cleavage of NLG1,
we show an overall reduction in excitatory transmission and release probability concurrent
with NRX1β loss (Figure 6). These findings support that the NLG-NRX complex is a critical
regulator of neurotransmitter release (Futai et al., 2007; Missler et al., 2003; Zhang et al.,
2005) and provide new evidence that NLG1-dependent regulation of presynaptic function
can occur over time scales of minutes.
In mature hippocampal and cortical cultures, postsynaptic receptor blockade increases
mEPSC frequency (Burrone et al., 2002; Thiagarajan et al., 2005; Wierenga et al., 2006) and
augments presynaptic terminal size and release probability (Murthy et al., 2001; Thiagarajan
et al., 2005). By contrast, local stimulation of dendrites acutely reduces release probability
of contacting presynaptic terminals (Branco et al., 2008). These data have implied the
existence of local trans-synaptic negative feedback signals capable of modifying presynaptic
function based on postsynaptic activity, the identity of which remains unknown. Our results
indicate that NLG1 cleavage is bi-directionally regulated by activity (Figures 3A and 3B).
Moreover, acute NLG1 cleavage decreases release probability whereas expression of a
cleavage-resistant NLG1 isoform induces the opposite effect (Figure 6). Together, these data
support a model where increased or decreased local NLG1 cleavage alternately dampens or
augments presynaptic function based on postsynaptic activity, thereby contributing to
overall levels of neuronal excitability.
MMP-9 Dependent Cleavage of Neuroligin-1 in Development and Disease
The developmental profile of NLG1-NTFs in the brain (Figures 2G and 2H) indicates that
NLG1 cleavage is upregulated during early stages of development, a time when activity-
dependent mechanisms sculpt new circuits (Hensch, 2004). Moreover, our results indicate
that MMP9-dependent cleavage of NLG1 is regulated by sensory experience during visual
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cortex maturation (Figures 7E and 7F). Interestingly, tissue plasminogen activator, a robust
activator of MMP9 (Wang et al., 2003), regulates synapse maintenance during cortical
development (Mataga et al., 2004) whereas MMP9 inhibition accelerates spine maturation in
cultures (Bilousova et al., 2009). It will be interesting to address if NLG1 cleavage is
involved in the activity-dependent mechanisms underlying synaptic maturation during
development.
In addition, MMP9-dependent cleavage of NLG1 is increased during status epilepticus in the
hippocampus of adult mice, indicating that this mechanism occurs in vivo not only during
development but also in mature circuits. Interestingly, MMP9 is upregulated and activated
during seizures and in turn induces extensive synaptic plasticity and remodeling of
hippocampal circuits (Szklarczyk et al., 2002; Wilczynski et al., 2008). Although our results
indicate that postsynaptic structure and function remain largely unaffected following NLG1
cleavage (Figures 5A, 5B, 5F and Movie S1), it remains to be determined whether further
processing or long-term loss of NLG1 can impact postsynaptic function and stability.
Finally, several NLG and NRX mutations have been linked to autism spectrum disorders
(ASDs) (Sudhof, 2008). In humans, ASDs emerge during the first years of infancy and are
often associated with epileptic disorders. Our results implicate NLG1 cleavage with
epileptiform activity and maturation of developing neuronal circuits. The acute proteolytic
regulation of neuroligins reported here may provide novel insight into the
pathophysiological mechanisms and therapeutic strategies for synaptic dysfunction in ASDs.
More broadly, such a mechanism may provide a general paradigm for trans-synaptic
signaling in diverse neural circuits.
Experimental Procedures
DNA Constructs and Antibodies
PSD-95-mCh was a gift from Thomas Blanpied (University of Maryland). mCherry-N1
vector was a gift from Roger Tsien (University of California, San Diego). Rat GFP-NLG1 in
pcDNA3 (ΔA splice variant) was kindly provided by Ann Marie Craig (University of British
Columbia), and NRX1β-mCh was a gift from Thomas Sudhof (Stanford University).
Antibodies are listed in supplemental methods.
Biochemical Analysis of Brain, Whole Cell Extracts, and PSD Fractions
Whole cell, synaptic plasma membrane, and PSD fractions from high density neuronal
cultures were prepared and analyzed as described previously (Ehlers, 2003).
Surface Biotinylation and Isolation of Soluble Cleavage Products
Biotinylation-based internalization assay was performed as described previously (Ehlers,
2000). For isolation of soluble cleavage products DIV21 cortical cultures were incubated in
PBS/Ca2+ with 1 mg/ml Sulfo-LC-Biotin-NHS (Pierce) for 10 min at 37°C. Cultures were
washed in PBS/Ca2+ with 10 mM Tris pH 7.4, rinsed 2x in PBS/Ca2+, and incubated in
conditioned media at 37°C for the indicated time period. Pharmacological inhibitors were
added 5 min prior to manipulations of neuronal activity. After incubation, culture media was
collected, supplemented with protease inhibitors (Roche), and centrifuged at 16,000 x g for
20 min. For surface-labeled controls, cultures were washed 2x with PBS/Ca2+, immediately
lysed with precipitation buffer (PBS with 1% Triton X-100, 5 mM EDTA, 10 mM L-lysine
pH7.4), sonicated, and centrifuged at 16,000 x g for 20 min. Supernatants were incubated
overnight with 50 μl NeutrAvidin Plus UltraLink Resin (Pierce) at 4°C. For NMDA
stimulation, cells were incubated in media containing 50 μM NMDA for 5 min and
subsequently incubated in conditioned media for 2 h. Both media samples were pooled
before streptavidin precipitation. For all samples, precipitated proteins were boiled in 2x
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sample buffer and resolved by SDS-PAGE prior to immunoblot analysis. For APMA
experiments, 50 mM APMA stock was solubilized in 0.1 N NaOH and 10 mM HEPES pH
7.4 was added to culture media.
In Utero Electroporation
E15.5 timed-pregnant C57BL/6 mice were anesthetized by 2% isoflurane. Uterine horns
were gently mobilized from the peritoneal cavity and 1 μg/μl of GFP-NLG1 or GFP-NLG1-
ΔSD3 and tdTomato cDNAs were injected into the lateral ventricle of the left hemisphere of
intrauterine embryos using a ~50 μm diameter pipette sharply beveled at 15–20° (Narishige,
Japan). DNA was transfected with five electrical pulses with a 1 s interval (50 V, 50 ms)
(CUY21 electroporator, NEPA GENE, Japan).
Slice Culture Preparation
Organotypic hippocampal slice cultures were prepared from 8 d old mice and cut with ~400
μm thickness. 3–5 slices were placed in a sterile culture plate insert (Millicell-CM,
Millipore). DNA constructs were biolistically transfected with a Helios Gene Gun (Biorad) 2
d later.
Two-Photon Microscopy and Glutamate Uncaging
Uncaging of MNI-glutamate and spine/dendrite imaging were performed using a custom-
built microscope combining two-photon laser-scanning microscopy (2PLSM) and two-
photon laser photoactivation (2PLP) as previously described (Kwon and Sabatini, 2011).
Organotypic or acute brain slices were placed in a slice chamber perfused with normal
ACSF containing (in mM) 127 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1
MgCl2 and 25 glucose. Dendrite/spine images were acquired with 840 nm excitation
wavelength and photolysis of MNI-glutamate was performed by focal illumination with 720
nm light. The laser power arriving at the specimen (10~15 mW) was controlled by Pockels
cells (Conoptics, Danbury, CT). Uncaging was done ~1 μm away from the spine head and
80 laser pulses (4 ms) were delivered at 2 Hz. Spine/dendrite image stacks were taken
immediately before and after the induction protocol (< 1 min). To analyze changes of GFP-
NLG1, green fluorescence (G) measured in the spine head or subjacent dendrite was
normalized to the red signal (R) from the same area and changes in the G/R ratios compared
before and after the induction protocol.
Confocal Imaging and FM4-64 Unloading Experiments
Confocal images of fixed samples and live cells were obtained using a Perkin Elmer
Ultraview spinning disc confocal microscope with either a 40x 1.3 N.A. objective or a 60x
1.4 N.A. objective. For immunocytochemistry, DIV21 hippocampal neurons were fixed in
4% paraformaldehyde/4% sucrose in PBS for 20 min, permeabilized with 0.2% Triton
X-100 for 15 min, and incubated with indicated antibodies. For live imaging, cells were
imaged in E4 media (in mM) 10 HEPES, 120 NaCl, 3 KCl, 10 D-glucose, 2 CaCl2, 2 MgCl2
at 37°C. Maximum projections of individual stacks were analyzed using Metamorph
software (Universal Imaging Corporation). Results shown correspond to the average of all
neurons per condition. Statistical significance was determined by unpaired t-test and error
bars represent standard error of the means.
FM4-64 (10 μM) uptake was performed using 90 mM KCl loading media (in mM) 10
HEPES, 33 NaCl, 90 KCl, 10 D-glucose, 2 CaCl2, 2 MgCl2, 20 μM NBQX, 50 μM APV for
1 min. Cells were washed 3x in washing buffer (WB: E4 with 0.5 mM CaCl2 and 10 mM
MgCl2) for 30 s, 2x for 15 s in WB containing 1 mM ADVASEP-7 (Sigma), and 3x in WB.
FM4-64 fluorescence was acquired with 567 nm excitation and a 647 nm emission filter.
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GFP imaging was done at the end of each time lapse to minimize photobleaching. Unloading
solution (in mM) 10 HEPES, 63 NaCl, 60 KCl, 10 D-glucose, 2 CaCl2, 2 MgCl2, 20 μM
NBQX, 50 μM APV was added with a precision of <2 s. Time constants (τ) of FM4-64
fluorescence decay at boutons corresponding to each condition were pooled and analyzed by
a Kolmogorov-Smirnov test. Statistical significance was determined using unpaired t-tests.
For more details see supplemental methods.
Electrophysiological Recordings
EPSC internal solution (in mM): 30 CsSO4, 70 K2SO4, 25 HEPES, 25 N-methyl-D-
glucamine, 0.1 CaCl2, 1 EGTA, 2 (Na)ATP, and 0.1 leupeptin, pH 7.2, ~300 mOsm; EPSC
external solution (in mM): 150 NaCl, 5 KCl, 10 HEPES, 1 MgCl2, 30 D-glucose, 2 CaCl2,
and 30 μM bicuculline). Only cells with series resistance <30 MΩ and <20% change in input
resistance, series resistance, and holding current were analyzed. EPSCs were evoked with a
concentric bipolar stimulating electrode (200 μs pulse duration). Paired-pulse responses (100
ms interval) were evoked every 30 s by stimulation of nearby cells. For mEPSC recordings
external solution contained additional 1 μM TTX. mIPSC internal solution (in mM): 150
KCl, 3 MgCl2, 15 HEPES, 0.1 CaCl2, 1 EGTA, 2 Na2ATP, and 0.1 leupeptin, pH 7.2, ~300
mOsm). mIPSC external solution contained 1 μM TTX, 50 μM D-APV, and 10 μM CNQX
instead of bicuculline. All currents were recorded at −70 mV voltage clamp.
Pilocarpine-Induced Status Epilepticus
P60 female FVB or FVB.Cg-Mmp9tm1Tvu/J mice (~18–25 g) were injected intraperitoneally
(i.p.) with 1 mg/kg scopolamine methylnitrate (Sigma) 30 min prior to experiment. Status
epilepticus was induced by i.p. injection of 315 mg/kg pilocarpine hydrochloride (Sigma)
while controls were injected with vehicle alone (sterile 0.9% NaCl). Experiment was
terminated 2 h later and hippocampal tissue was collected and flash frozen. Only animals
with class IV or higher seizures were used for analysis.
Dark Rearing Experiments
Male and female FVB or FVB.Cg-Mmp9tm1Tvu/J mice were reared in a normal light dark
cycle (12 h light/12 h light) from birth until P26 (LR) or were transferred to a dark room in
complete darkness at P21 (DR). DR+2hL group was re-exposed to light for 2 h before
euthanization. Primary visual cortex was extracted, and homogenized as described
previously.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Neuronal Activity Triggers Loss of Neuroligin-1 from Synapses
(A) Hippocampal neurons (DIV21) incubated in media (Control) or media with 30 mM KCl
for 2 h (KCl) immunolabeled for PSD-95 and pan-NLG (NLG1-4). Arrows show NLG1-4
labeling at PSD-95+ synapses under control conditions (open) or after KCl (solid). Boxed
regions are magnified in lower panels. Scale bars, 5 μm and 1 μm.
(B) Means ± SEM of NLG1-4 FL intensity in PSD-95+ spines (left) or entire neuron (right)
normalized to controls. Control, n = 435 puncta, 8 neurons; KCl, n = 546 puncta, 9 neurons.
* p < 0.01.
(C) Immunoblot analysis of NLG1 in membrane fractions isolated from control (Ctrl) or
KCl-treated cortical neurons (DIV21). EXT, whole cell extract; SPM, synaptic plasma
membrane; PSDI,II, III; postsynaptic density fractions. Note that 4-fold less protein by mass
was loaded in PSD fraction lanes. See Experimental Procedures for details.
(D) Means ± SEM of NLG1 protein levels relative to EXT control. n = 3, *p < 0.05,
**p<0.005, ***p<0.001.
(E) Biotinylation assay of endocytosis performed on DIV21 cortical neurons incubated in
media (Ctrl) or media with 30 mM KCl. Surf- Total surface protein at time zero. See
Experimental Procedures for details.
(F) Quantitative analysis of NLG1 (left) and GluA1 (right) internalization over time.
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(G) Immunoblot of NLG1 in lysates of DIV21 cortical cultures following 2 h incubation in
medium (Ctrl) or medium with 30 mM KCl alone or supplemented with MG132 (10 μM),
leupeptin (200 μM), leupeptin+MG132 (Leup/MG), or GM6001 (10 μM). Note that
GM6001 prevents KCl-induced loss of total NLG1.
(H) Means ± SEM of total NLG1 under indicated conditions. n = 3, *p < 0.05.
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Figure 2. A Soluble N-Terminal Fragment of NLG1 is Abundant in Brain
(A) Diagram of biotinylation-based cleavage assay. Media from surface biotinylated
neuronal cultures was collected and soluble biotin conjugates isolated by streptavidin
precipitation.
(B) Immunoblot analysis of NLG1 reveals time-dependent release of soluble ~90 kDa
NLG1-NTFs to culture media. Lys- 10% Total surface protein at time zero.
(C) Deglycosylation induces an equivalent mass shift of both full-length NLG1 (Lysate) and
NLG1-NTFs (Media) collected after surface biotinylation.
(D) Immunoblot analysis of NLG1 in whole homogenates (5 μg, Total) and soluble (50 μg,
Sol) fractions obtained from cortical, hippocampal, and cerebellar tissue from P60 WT mice
reveals soluble ~90 kDa NLG1-NTFs.
(E) Deglycosylation of whole homogenates (total) and soluble fractions from P5 WT mouse
cortex results in a ~20 kDa apparent mass shift of NLG1-NTFs.
(F) Immunoblot analysis of NLG1 in whole brain homogenates (Total) and soluble fractions
(Sol) from WT and NLG1-KO mice reveals absence of NLG1-NTFs in NLG1-KO tissue.
(G) Developmental profile of NLG1-NTFs from WT mouse cortical extracts at different
postnatal days (P). Total, 10 μg whole cortical homogenates; Sol, 50 μg soluble fractions.
Peixoto et al. Page 19













(H) Line scan analysis of immunoblots shown in (G) Note that the relative abundance of
NLG1-NTFs is higher during early developmental stages. The graph plots signal intensity
along the lines shown on the blots on the left.
(I) Immunoblot analysis of NLG1-CTFs in total homogenates (Total), soluble fractions
(Sol), and membrane fractions (Memb) of P60 WT mouse cortex.
(J) Immunoblot analysis of NLG1-CTFs in whole brain homogenates from WT and NLG1-
KO mice reveals the absence of ~20 kDa NLG1-CTFs in NLG1-KO tissue.
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Figure 3. Neuronal Activity Induces NLG1 Cleavage Through NMDAR, CaMK, and MMP9
Signaling
(A) Isolation and detection of NLG1-NTFs under control conditions or in the presence of
TTX (2 μM) or bicuculline (50 μM) plus 4AP (25 μM, Bic/4AP). Surface- 10% of total
surface protein at time zero.
(B) Means ± SEMs of NLG1-NTFs under indicated conditions normalized to control. n = 4,
* p< 0.05.
(C) Isolation and detection of NLG1-NTFs under control conditions or in the presence of
KCl (30 mM, 2 h) with or without indicated pharmacological agents.
(D) Means ± SEMs of NLG1-NTFs levels normalized to control. n = 4, * p< 0.05, ** p <
0.01.
(E) Isolation and detection of ~90 kDa NLG1-NTFs under control conditions or in the
presence of KCl with or without MMP inhibitors. Note that inhibitors targeting MMP9
abrogate KCl-induced NLG1 cleavage.
(F) Means ± SEMs of NLG1-NTFs levels normalized to control. n = 8, *p < 0.005. n.s., not
significant.
(G) Immunoblot analysis of NLG1 and NLG1-NTFs in biotinylated fractions of
DIV21cortical neurons treated with the nonselective MMP activator APMA with or without
MMP inhibitors. Lys- Whole lysates; Med- Media. Note that only 10% of precipitate was
loaded in Lys lanes.
(H) Means ± SEMs of NLG1-NTFs produced under the indicated conditions normalized to
control. n = 3, *p < 0.05.
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(I–J) Immunoblot analysis of NLG1 in whole cell extracts from DIV18 cortical neuron
cultures from (I) WT or (J) MMP9 KO mice following 2 h incubation in Neurobasal
medium (Control) or medium with 30mM KCl (KCl). Bar graphs on the right represent
means ± SEM of total NLG1 levels under the indicated conditions for WT (n = 6, *p < 0.01)
and MMP9 KO neurons (n = 6, p > 0.05), respectively.
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Figure 4. Local Glutamate Uncaging Triggers Rapid Cleavage of Synaptic NLG1
(A) Model illustrating the NLG1-ΔSD substitution mutants in relation to NLG1 domains.
AChED, acetylcholinesterase homology domain; DD, dimerization domain; SD, stalk
domain; TM, transmembrane domain; CT, C-terminal domain. Numbers indicate amino
acids.
(B) Biotinylation-based cleavage assay of COS7 cells expressing the indicated NLG1
mutants. Total lysates (Lys) or media (Med) were collected and subjected to immunoblot
analysis following treatment with the MMP activator APMA with or without the broad
spectrum MMP inhibitor GM6001 (GM). Both NLG1-ΔSDfull and NLG-ΔSD3 were
resistant to APMA-induced cleavage indicating that MMP cleavage sites lie between
residues 672 and 695.
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(C) Time-lapse images of hippocampal neurons expressing GFP-NLG1 and tdTomato
before and after glutamate uncaging. The yellow dot represents the uncaging spot. “1”
represents the dendritic spine stimulated with glutamate and “2” represents a neighboring
spine within 10 μm of spine 1. Dashed white line represents the contour used for
fluorescence analysis in (F). Scale bars, 2μm.
(D) Same as (C) but glutamate uncaging was performed in the presence of MMP2/9
inhibitor II (0.3 μM). Scale bar, 2μm.
(E) Same as (C) but cells express GFP-NLG1-ΔSD3 and tdTomato. Scale bar, 2μm.
(F–H) Fluorescence intensity profiles of GFP (green) and tdTomato (red) along the white
dashed lines depicted in (C–E).
(I) Representation of the dendrite segment depicted in (E) illustrating analysis of GFP and
tdTomato fluorescence in dendritic spines and adjacent dendritic shaft regions.
(J–L) Means ± SEMs of GFP/tdTomato fluorescence intensity ratio after glutamate uncaging
in dendritic spines and adjacent dendritic shaft regions in the conditions represented in (C–
E), respectively. n = 10, 11 and 11; *p<0.05, **p<0.001.
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Figure 5. Juxtamembrane Cleavage of Neuroligin Destabilizes Presynaptic Neurexin-1β
(A) Left, schematic of thrombin-cleavable NLG1. Right, DIV21 hippocampal neurons
expressing GFP-Thr-NLG1 and mCherry for 3–5 d were imaged before (Pre) and 30 min
after (Post) thrombin incubation. Scale bar, 5 μm.
(B) Same as (A) but neurons expressed GFP-Thr-NLG1 and PSD-95-mCh. Scale bar, 5 μm.
(C) Dually-labeled synapses with postsynaptic GFP-Thr-NLG1 and presynaptic NRX1β-
mCh imaged by confocal microscopy before (Pre) and 30 min after (Post) thrombin
incubation. Solid arrowheads show loss of presynaptic NRX1β-mCh apposed to
postsynaptic GFP-Thr-NLG1 puncta. Open arrowheads show generation of mobile NRX1β-
mCh puncta along the axon. Scale bar, 5 μm.
(D) Same as (C) but cells were co-transfected with GFP-Thr-NLG1 and synaptophysin-mCh
(Sph-mCh). Sph-mCh is not affected GFP-Thr-NLG1 cleavage. Scale bar, 5 μm.
(E) Timelapse of the highlighted region depicted in (C). The red arrowhead shows the time
of thrombin (Thr) application. Scale bar, 5 μm.
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(F) Means ± SEM of fluorescence intensity change 30 min after thrombin (Thr) cleavage at
synapses expressing GFP-Thr-NLG1. mCherry, n = 307 spines; PSD-95-mCh, n = 403
spines; Sph-mCh, n = 43 synaptic pairs; NRX1β-mCh, n = 87 synaptic pairs, *p <0.05.
(G) Fluorescence intensity before and after thrombin application at synapses containing
presynaptic NRX1β-mCh and postsynaptic GFP-Thr-NLG1. Arrowhead shows time of
thrombin (Thr) application. n = 87 synaptic pairs.
(H) Same as (G) but neurons expressed GFP-NLG1 lacking a thrombin cleavage site. n = 76
synaptic pairs.
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Figure 6. NLG1 Cleavage Rapidly Reduces Release Probability at Excitatory Synapses
(A) Miniature EPSCs (mEPSCs) recorded before (Baseline) and after (Post) thrombin
treatment in hippocampal neurons (DIV15-25) expressing GFP-Thr-NLG1 or GFP-NLG1.
(B) Means ± SEM of mEPSC frequency and (C) amplitude change after thrombin incubation
in neurons expressing GFP-NLG1 or GFP-Thr-NLG1. n = 8, 5 for GFP-Thr-NLG1 and
GFP-NLG1, respectively. *p < 0.01.
(D) Paired-pulse evoked EPSCs (eEPSCs) recorded before (Baseline) or after (Post)
thrombin treatment in hippocampal neurons (DIV15-25) expressing GFP-Thr-NLG1 or
GFL-NLG. Insets depict traces before and after thrombin treatment, normalized to the
amplitude of the first EPSP.
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(E) Means ± SEM of eEPSC amplitude change after thrombin in neurons expressing GFP-
NLG1 or GFP-Thr-NLG1. n = 6, 6; *p < 0.05.
(F) Means ± SEM of paired-pulse ratio change after thrombin in neurons expressing GFP-
NLG1 or GFP-Thr-NLG1. n = 6, 6; *p < 0.05.
(G) Means ± SEM of time constants (τ) from stimulus-induced FM4-64 fluorescence decay
measurements in presynaptic terminals apposing neurons expressing GFP-NLG1 or GFP-
NLG1-ΔSD3. Terminals in GFP-NLG1-ΔSD3 synapses exhibit faster FM4-64 decay
kinetics. GFP-NLG1-ΔSD3, n = 396 terminals, 12 neurons; GFP-NLG1, n = 438 terminals,
11 neurons; ***p<0.0001
(H) Cumulative distribution of FM4-64 decay constants (τ) of terminals analyzed in (G).
(I) Representative kymographs of FM4-64 intensity in terminals apposing GFP-NLG1 or
GFP-NLG1-ΔSD3. Arrowhead indicates time of KCl application.
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Figure 7. NLG1 Cleavage is Triggered by Neural Activity and Sensory Experience In Vivo
(A) WT and MMP9 KO mice were injected with pilocarpine (315 mg/kg) or saline (control)
for 2 h.
(B) Immunoblot analysis of total extracts (5 μg) and soluble fractions (Sol, 50 μg) of
hippocampi from mice injected with pilocarpine or saline (control). Arrow indicates
increased NLG1-NTFs after PSE in WT mice.
(C) Means ± SEMs of NLG1-NTFs levels in indicated conditions normalized to control. n =
9 animals in each WT group; n = 10, 11 in MMP9 KO control and pilocarpine groups,
respectively. *p < 0.005.
(D) WT and MMP9-KO mice were reared in a normal 12 h day/night cycle (LR) for 26 d or
submitted to dark rearing for 5 d from P21-P26 (DR). DR+2hL indicates group submitted to
2 h light exposure (yellow box) after DR.
(E) Immunoblot analysis of primary visual cortex soluble fractions of P26 mice reared under
different conditions. α-actinin (α-Act) was used as a loading control.
(F) Means ± SEM of NLG1-NTFs levels under different conditions normalized to LR
groups. n = 27 animals in each WT group; n = 24, 25, 28 animals in MMP9 KO LR, DR and
DR+2hL groups, respectively. *p < 0.01.
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